303 related articles for article (PubMed ID: 27611878)
1. Structural biology in antiviral drug discovery.
Bassetto M; Massarotti A; Coluccia A; Brancale A
Curr Opin Pharmacol; 2016 Oct; 30():116-130. PubMed ID: 27611878
[TBL] [Abstract][Full Text] [Related]
2. Editorial overview: Engineering for viral resistance.
von Brunn A
Curr Opin Virol; 2015 Oct; 14():v-vii. PubMed ID: 26320757
[No Abstract] [Full Text] [Related]
3. Editorial overview: antivirals and resistance: advances and challenges ahead.
Menéndez-Arias L; Richman DD
Curr Opin Virol; 2014 Oct; 8():iv-vii. PubMed ID: 25155454
[No Abstract] [Full Text] [Related]
4. A prospects tool in virus research: Analyzing the applications of organoids in virus studies.
Shen Q; Zhou YH; Zhou YQ
Acta Trop; 2024 Jun; 254():107182. PubMed ID: 38479469
[TBL] [Abstract][Full Text] [Related]
5. Recent progresses in marine microbial-derived antiviral natural products.
Teng YF; Xu L; Wei MY; Wang CY; Gu YC; Shao CL
Arch Pharm Res; 2020 Dec; 43(12):1215-1229. PubMed ID: 33222073
[TBL] [Abstract][Full Text] [Related]
6. Human viral diseases: what is next for antiviral drug discovery?
De Clercq E
Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
[TBL] [Abstract][Full Text] [Related]
7. In Silico Drug Discovery for Treatment of Virus Diseases.
Joon S; Singla RK; Shen B
Adv Exp Med Biol; 2022; 1368():73-93. PubMed ID: 35594021
[TBL] [Abstract][Full Text] [Related]
8. Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.
Naesens L; Zoulim F
Curr Opin Virol; 2017 Jun; 24():v-vii. PubMed ID: 28743435
[No Abstract] [Full Text] [Related]
9. The program of antiviral agents inhibits virus infection.
Ding YZ; Lv JL; Zhang ZW; Ma XY; Zhang J; Zhang YG
Arch Microbiol; 2018 Aug; 200(6):841-846. PubMed ID: 29846759
[TBL] [Abstract][Full Text] [Related]
10. X-ray crystallography as a tool for mechanism-of-action studies and drug discovery.
Ennifar E
Curr Pharm Biotechnol; 2013; 14(5):537-50. PubMed ID: 22429136
[TBL] [Abstract][Full Text] [Related]
11. 4-Oxoquinoline Derivatives as Antivirals: A Ten Years Overview.
Batalha PN; da S M Forezi L; Tolentino NMC; Sagrillo FS; de Oliveira VG; de Souza MCBV; da C S Boechat F
Curr Top Med Chem; 2020; 20(3):244-255. PubMed ID: 31995008
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Spirooxindoles as Antiviral Agents.
Ye N; Chen H; Wold EA; Shi PY; Zhou J
ACS Infect Dis; 2016 Jun; 2(6):382-92. PubMed ID: 27627626
[TBL] [Abstract][Full Text] [Related]
13. Structure-based drug discovery and protein targets in the CNS.
Hubbard RE
Neuropharmacology; 2011 Jan; 60(1):7-23. PubMed ID: 20673774
[TBL] [Abstract][Full Text] [Related]
14. New horizons for antiviral drug discovery from virus-host protein interaction networks.
de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912
[TBL] [Abstract][Full Text] [Related]
15. 1,3,4-oxadiazole: a privileged structure in antiviral agents.
Li Z; Zhan P; Liu X
Mini Rev Med Chem; 2011 Nov; 11(13):1130-42. PubMed ID: 22353222
[TBL] [Abstract][Full Text] [Related]
16. Nucleic acid-based drugs against emerging zoonotic viruses.
Wong JP
Future Med Chem; 2015; 7(13):1709-19. PubMed ID: 26399689
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery.
Coutard B; Decroly E; Li C; Sharff A; Lescar J; Bricogne G; Barral K
Antiviral Res; 2014 Jun; 106():61-70. PubMed ID: 24704437
[TBL] [Abstract][Full Text] [Related]
18. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains.
Shin WJ; Seong BL
Expert Opin Drug Discov; 2019 Feb; 14(2):153-168. PubMed ID: 30585088
[TBL] [Abstract][Full Text] [Related]
19. Protein-protein interactions as targets for antiviral chemotherapy.
Loregian A; Marsden HS; Palù G
Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
[TBL] [Abstract][Full Text] [Related]
20. Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.
Prasad M; Ranjan K; Brar B; Shah I; Lalmbe U; Manimegalai J; Vashisht B; Gaury M; Kumar P; Khurana SK; Prasad G; Rawat J; Yadav V; Kumar S; Rao R
Curr Drug Metab; 2017; 18(10):942-970. PubMed ID: 28952435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
